Aug 31, 2025, 22:51
Miloš Grujić: Clinical Outcomes of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma
Miloš Grujić, Co-Chair of Career Development Working Group at European School of Oncology, shared a post on X:
“Our new paper is out in Cancers!
Ultra-low-dose RT (4 Gy/2 fr) achieves excellent control and safety in ocular adnexal lymphoma.
Big thanks to my amazing co-authors.”
Title: Clinical Outcomes and Safety of Ultra-Low-Dose Radiotherapy for Ocular Adnexal Lymphoma: A Systematic Review
Journal: Cancers
Authors: Miloš Grujić, Stanislav Volchenkov, Aidos Akhmetali, Marija Živković Radojević, Neda Milosavljević, Katarina Janković, Katarina Krasić, Milica Mihajlović, Mohamed Shelan, Luca Nicosia, Mladen Marinković
More posts featuring Miloš Grujić on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 31, 2025, 22:28
Aug 31, 2025, 22:18
Aug 31, 2025, 21:24
Aug 31, 2025, 20:04
Aug 31, 2025, 20:00
Aug 31, 2025, 19:34
Aug 31, 2025, 19:32